Next Article in Journal
Malaria Vaccine Introduction in Cameroon: Early Results 30 Days into Rollout
Next Article in Special Issue
Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination
Previous Article in Journal
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac® and ChAdOx1-S Vaccines for SARS-CoV-2
Previous Article in Special Issue
A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides
 
 
Article

Article Versions Notes

Vaccines 2024, 12(4), 345; https://doi.org/10.3390/vaccines12040345
Action Date Notes Link
article xml file uploaded 22 March 2024 16:09 CET Original file -
article xml uploaded. 22 March 2024 16:09 CET Update -
article pdf uploaded. 22 March 2024 16:09 CET Version of Record https://www.mdpi.com/2076-393X/12/4/345/pdf-vor
article html file updated 22 March 2024 16:12 CET Original file -
article xml file uploaded 16 April 2024 11:48 CEST Update -
article xml uploaded. 16 April 2024 11:48 CEST Update -
article pdf uploaded. 16 April 2024 11:48 CEST Updated version of record https://www.mdpi.com/2076-393X/12/4/345/pdf-vor
article html file updated 16 April 2024 11:49 CEST Update -
article pdf uploaded. 14 June 2024 11:26 CEST Minor correction https://www.mdpi.com/2076-393X/12/4/345/pdf
article xml uploaded. 14 June 2024 11:26 CEST Minor correction https://www.mdpi.com/2076-393X/12/4/345/xml
article supplementary file uploaded. 14 June 2024 11:26 CEST - https://www.mdpi.com/2076-393X/12/4/345#supplementary
article html file updated 14 June 2024 11:28 CEST Update https://www.mdpi.com/2076-393X/12/4/345/html
Back to TopTop